Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-melanoma-at-2024-esmo-annual-meeting-302249003.html
02 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-issuance-of-composition-of-matter-patent-for-lns8801-by-the-european-patent-office-302105941.html
06 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-uveal-melanoma-at-2023-asco-annual-meeting-301843582.html
19 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-granted-orphan-drug-designation-for-lns8801-for-the-treatment-of-patients-with-metastatic-cutaneous-melanoma-301725268.html
21 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-issuance-of-patent-for-lns8801-by-the-us-patent-and-trademark-office-301629751.html
12 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-lns8801-clinical-data-at-2022-esmo-annual-meeting-301621714.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?